mTBI Detection

About ABCDx

ABCDx is a private, pre-revenue diagnostics company developing a novel platform for point-of-care brain injury assessment. Founded in 2015 and based in Geneva, Switzerland, with a significant operational presence in Barcelona, Spain, the company's core technology revolves around blood-based biomarkers and a proprietary software platform to differentiate stroke types and detect mild TBI. Led by scientific founders who are key opinion leaders in brain biomarkers, ABCDx is building a robust intellectual property portfolio with granted patents in key markets including the U.S., China, and Europe, positioning itself to address critical unmet needs in neuro-emergency diagnostics.

Therapeutic Areas